A0061305 Screening compound: 3-cyclohexyl-N-(2,3-dihydro-1H-inden-5-yl)-4-oxo-2-sulfanylidene-1,2,3,4-tetrahydroquinazoline-7-carboxamide

A0061305 Screening compound: 3-cyclohexyl-N-(2,3-dihydro-1H-inden-5-yl)-4-oxo-2-sulfanylidene-1,2,3,4-tetrahydroquinazoline-7-carboxamide
A0061305 Screening compound: 3-cyclohexyl-N-(2,3-dihydro-1H-inden-5-yl)-4-oxo-2-sulfanylidene-1,2,3,4-tetrahydroquinazoline-7-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound A0061305
3-cyclohexyl-N-(2,3-dihydro-1H-inden-5-yl)-4-oxo-2-sulfanylidene-1,2,3,4-tetrahydroquinazoline-7-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

A0061305

Molecular Formula

C24H25N3O2S (C24 H25 N3 O2 S)

Compound Name

3-cyclohexyl-N-(2,3-dihydro-1H-inden-5-yl)-4-oxo-2-sulfanylidene-1,2,3,4-tetrahydroquinazoline-7-carboxamide

IUPAC name

3-cyclohexyl-N-(23-dihydro-1H-inden-5-yl)-4-oxo-2-sulfanylidene-1234-tetrahydroquinazoline-7-carboxamide

SMILES

O=C(c(cc1)cc(NC(N2C3CCCCC3)=S)c1C2=O)Nc1cc(CCC2)c2cc1

InChI

InChI=1S/C24H25N3O2S/c28-22(25-18-11-9-15-5-4-6-16(15)13-18)17-10-12-20-21(14-17)26-24(30)27(23(20)29)19-7-2-1-3-8-19/h9-14,19H,1-8H2,(H,25,28)(H,26,30)

InChI Key

NUWSKADSRQSZAB-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD02649406

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

419.55

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

5.266

Distribution Coefficient, logD

5.262

Water Solubility, LogSw

-5.49

Polar Surface Area

49.917

Acid Dissociation Constant (pKa)

9.42

Base Dissociation Constant (pKb)

-1.92

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

37.50

A0061305 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with A0061305 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound A0061305?
Check Price and Availability of A0061305, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of A0061305 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for A0061305
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for A0061305
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of A0061305 available by request